These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2172590)

  • 1. [Cytomegalovirus pneumonia after bone marrow transplantation].
    Irie S; Kodo H
    Nihon Rinsho; 1990 Sep; 48(9):2068-72. PubMed ID: 2172590
    [No Abstract]   [Full Text] [Related]  

  • 2. CMV prophylaxis in allogeneic BMT with ganciclovir and CMV immune globulin.
    Patton WN; Carter C; Bienz N; Lamb T; Boughton BJ; Franklin IM
    Bone Marrow Transplant; 1991; 7 Suppl 2():44. PubMed ID: 1652330
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary infections after bone marrow transplant.
    Cunningham I
    Semin Respir Infect; 1992 Jun; 7(2):132-8. PubMed ID: 1439322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group.
    Atkinson K; Arthur C; Bradstock K; Dale B; Downs K; Gibson J; Golenia M; Ho J; Joshua D; Juttner C
    Bone Marrow Transplant; 1995 Sep; 16(3):401-5. PubMed ID: 8535313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganciclovir and standard high-dose immunoglobulins for the treatment of cytomegalovirus interstitial pneumonia in a bone marrow recipient.
    Iori AP; Gentile G; Petasecca Donati P; Arcese W; Martino P; Mandelli F
    Haematologica; 1990; 75(4):394-6. PubMed ID: 2177441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulin.
    Krischer J; Elfenbein G; Babington R; Hong R; Jansen J; Lazarus H; Winton E; Rand K
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):89-95. PubMed ID: 1324530
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with sandoglobulin in bone marrow transplantation.
    Tutschka PJ; Copelan EA
    Int J Cell Cloning; 1986; 4 Suppl 1():181-8. PubMed ID: 3018102
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of infection after bone marrow transplantation].
    Schmeiser T
    Fortschr Med; 1991 Feb; 109(6):155-7. PubMed ID: 1646147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serological diagnosis of cytomegalovirus-induced interstitial pneumonia in patients following bone marrow transplantation].
    Müller A; Pustowoit B; Arnold U; Hoffmann FA; Kubel M; Raue I; Friedrich T
    Z Gesamte Inn Med; 1991 Aug; 46(12):443-6. PubMed ID: 1659048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of cytomegalovirus infection and disease in the transplantation patient].
    Cisneros JM; Pachón J
    Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):40-4. PubMed ID: 8384888
    [No Abstract]   [Full Text] [Related]  

  • 11. Should all CMV infections after bone marrow transplantation be treated?
    Jouet JP; Draoui A; Facon T; Noel-Walter MP; Wattre P; Fenaux P; Dupriez B; Morel P; Bauters F
    Bone Marrow Transplant; 1991; 7 Suppl 2():47. PubMed ID: 1652333
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical, diagnostic and physiopathological aspects of cytomegalovirus pneumonia after bone marrow transplantation].
    Cordonnier C
    Rev Pneumol Clin; 1990; 46(6):244-50. PubMed ID: 1965751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early complications of bone marrow transplantation in children and adults.
    Tutschka PJ
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():22-6. PubMed ID: 2516755
    [No Abstract]   [Full Text] [Related]  

  • 14. Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients.
    Schmidt GM; Kovacs A; Zaia JA; Horak DA; Blume KG; Nademanee AP; O'Donnell MR; Snyder DS; Forman SJ
    Transplantation; 1988 Dec; 46(6):905-7. PubMed ID: 2849818
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous immunoglobulin in bone marrow transplantation.
    Gale RP; Winston D
    Cancer; 1991 Sep; 68(6 Suppl):1451-3. PubMed ID: 1652350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganciclovir in the treatment of cytomegalovirus pneumonitis in bone marrow transplant recipients.
    Milliken S; Powles R; Ettinger N; Gallagher C; Jameson B; Tryhorn Y; Stern H; Selby P
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3110-1. PubMed ID: 2539692
    [No Abstract]   [Full Text] [Related]  

  • 17. Interstitial pneumonia after allogeneic and autologous bone marrow transplantation.
    Funada H; Harada M; Yoshida T; Hattori K
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():519-30. PubMed ID: 6097710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance and efficacy of ganciclovir in the treatment of cytomegalovirus infections in immunosuppressed patients.
    Ho WG; Winston DJ; Champlin RE
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3103-6. PubMed ID: 2539690
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of CMV retinitis with ganciclovir after allogeneic marrow transplantation.
    Kaulfersch W; Urban C; Hauer C; Lackner H; Gamillscheg A; Slavc I; Langmann G
    Bone Marrow Transplant; 1989 Sep; 4(5):587-9. PubMed ID: 2551437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic adenine arabinoside following marrow transplantation.
    Kraemer KG; Neiman PE; Reeves WC; Thomas ED
    Transplant Proc; 1978 Mar; 10(1):237-40. PubMed ID: 205020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.